Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportInstrumentation & Data Analysis Track

Quantitative assessment of the Albira II PET/CT performance based on a range of radionuclides

Ali Asgar Attarwala, Yvonne Karanja, Chiara Romano, Deni Hardiansyah, Mareike Roscher, B Wängler, Sven Junge and Gerhard Glatting
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 395;
Ali Asgar Attarwala
3Medical Faculty Mannheim, Heidelberg University Mannheim Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yvonne Karanja
3Medical Faculty Mannheim, Heidelberg University Mannheim Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chiara Romano
3Medical Faculty Mannheim, Heidelberg University Mannheim Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deni Hardiansyah
6Teknik elektro, Universitas Padjadjaran, Bandung, Indonesia Bandung Indonesia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mareike Roscher
2German Cancer Research Centre Heidelberg Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B Wängler
5Molecular Imaging and Radiochemistry, Institute for Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany Mannheim Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sven Junge
1Bruker BioSpin MRI Ettlingen Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerhard Glatting
4Medical Radiation Physics, Department of Nuclear Medicine, Ulm University, Ulm, Germany Ulm Germany
3Medical Faculty Mannheim, Heidelberg University Mannheim Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

395

Objectives: The performance characteristics of the Albira II pre-clinical PET system for the radionuclides 18F, 68Ga, 64Cu and 89Zr was analyzed.

Methods: The Albira II tri-modal system (Bruker BioSpin MRI GmbH, Ettlingen, Germany) is a pre-clinical device for PET, SPECT and CT. The PET sub-system uses single continuous crystal detectors of lutetium yttrium orthosilicate (LYSO). The detector assembly consists of three rings of 8 detector modules. The transaxial and axial field of view (FOV) are of 80 mm and 148 mm, respectively. A NEMA NU-4 image quality phantom (Data Spectrum Corporation, Durham, USA) having five rods with diameters of 1, 2, 3, 4 and 5 mm and a uniform central region was used. Measurements with 18F, 68Ga, 64Cu and 89Zr were performed in list mode acquisition over 10 h. Data were reconstructed using a maximum-likelihood expectation-maximization (MLEM) algorithm with iteration numbers between 5 and 50. System sensitivity, spatial resolution, count rate linearity, convergence and recovery coefficients were analyzed.

Results: The sensitivities for the entire FOV (non-NEMA method) for 18F, 68Ga, 64Cu and 89Zr were (3.78±0.05) %, (3.97±0.18) % and (3.79±0.37) % and (3.42±0.19) %, respectively. The sensitivity based on the NEMA protocol using the 22Na point source yielded (5.53±0.06) %. The dead-time corrected true counts were linear for activities ≤ 7 MBq (18F and 68Ga), ≤ 17 MBq (64Cu) and ≤ 12 MBq (89Zr) and the adjusted R2 values were 蠅0.99. The spatial resolution calculated as per the NEMA protocol for a 22Na point source at the center of the FOV yielded full widths at half maximum values of 1.52 mm, 1.47 mm and 1.48 mm in the x, y and z orientation, respectively. Recovery coefficients for the uniform region with a total activity of 8 MBq in the phantom were (0.97±0.05), (0.98±0.06), (0.98±0.06) and (0.96±0.09) for 18F, 68Ga, 64Cu and 89Zr, respectively.

Conclusion: The Albira II pre-clinical PET system showed a good sensitivity range and the system linearity is suitable for the range of activities used for pre-clinical imaging. Overall, the system showed a favorable image quality for pre-clinical applications. Research Support: The authors gratefully acknowledge funding received for M²OLIE (Research Campus funded by the German Federal Ministry of Education and Research (BMBF) within the Framework “Forschungscampus: public-private partnership for Innovations”), MITIGATE from the European Community`s Seventh Framework Programme (FP7/2007-20013) under grant agreement no 602306 and Perspektivförderung ,,Translationale Radiochemie und Radiopharmazie“(Land Baden-Württemberg). Furthermore, the support by the “Bundesministerium für Bildung und Forschung” (Federal Ministry of Education and Research, BMBF 02NUK008F) and the “Bundesamt für Strahlenschutz” (Federal Office for Radiation Protection, BfS 3608S04001) for the establishment of the endowed professorship “Medizinische Strahlenphysik/Strahlenschutz” (Medical Radiation Physics/Radiation Protection) it is gratefully acknowledged. DH thanks the “Direktorat Jendral Pendidikan Tinggi” (Directorate General of Higher Education DIKTI of Ministry for Research, Technology and Higher Education, Republic Indonesia) for Grant Number: 2644/E4.4/K/2013.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 58, Issue supplement 1
May 1, 2017
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Quantitative assessment of the Albira II PET/CT performance based on a range of radionuclides
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Quantitative assessment of the Albira II PET/CT performance based on a range of radionuclides
Ali Asgar Attarwala, Yvonne Karanja, Chiara Romano, Deni Hardiansyah, Mareike Roscher, B Wängler, Sven Junge, Gerhard Glatting
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 395;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Quantitative assessment of the Albira II PET/CT performance based on a range of radionuclides
Ali Asgar Attarwala, Yvonne Karanja, Chiara Romano, Deni Hardiansyah, Mareike Roscher, B Wängler, Sven Junge, Gerhard Glatting
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 395;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Instrumentation & Data Analysis Track

  • Deep Learning Based Kidney Segmentation for Glomerular Filtration Rate Measurement Using Quantitative SPECT/CT
  • The Benefit of Time-of-Flight in Digital Photon Counting PET Imaging: Physics and Clinical Evaluation
  • Preclinical validation of a single-scan rest/stress imaging technique for 13NH3 cardiac perfusion studies
Show more Instrumentation & Data Analysis Track

Pre-Clinical Systems

  • Broadband X-ray Fluorescence Emission Tomography with A Small Pixel CdTe Imaging-Spectrometry Detector
  • Development of a SiPM based preclinical PET SPECT imaging system imaging system
  • A combined PET-EPR system: initial testing
Show more Pre-Clinical Systems

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire